Annual CAPEX
$4.13 M
-$4.94 M-54.47%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual capital expenditures is $4.13 million, with the most recent change of -$4.94 million (-54.47%) on December 31, 2023.
- During the last 3 years, RLAY annual CAPEX has risen by +$2.19 million (+113.67%).
- RLAY annual CAPEX is now -54.47% below its all-time high of $9.06 million, reached on December 31, 2022.
Performance
RLAY CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 1, 2024
Summary
- RLAY quarterly capital expenditures is not available.
Performance
RLAY Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 1, 2024
Summary
- RLAY TTM capital expenditures is not available.
Performance
RLAY TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
RLAY CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.5% | - | - |
| 3 y3 years | +113.7% | - | - |
| 5 y5 years | - | - | - |
RLAY CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.5% | +18.9% | ||||
| 5 y | 5-year | -54.5% | +113.7% | ||||
| alltime | all time | -54.5% | +113.7% |
Relay Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $1.78 M(+1408.5%) | $3.99 M(-3.3%) |
| Dec 2023 | $4.13 M(-54.5%) | $118.00 K(-80.0%) | $4.13 M(-34.8%) |
| Sep 2023 | - | $590.00 K(-60.7%) | $6.32 M(-19.2%) |
| Jun 2023 | - | $1.50 M(-21.5%) | $7.83 M(-4.3%) |
| Mar 2023 | - | $1.92 M(-17.3%) | $8.18 M(-9.7%) |
| Dec 2022 | $9.06 M | $2.32 M(+10.5%) | $9.06 M(+18.8%) |
| Sep 2022 | - | $2.10 M(+12.8%) | $7.63 M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $1.86 M(-33.5%) | $7.27 M(+25.5%) |
| Mar 2022 | - | $2.79 M(+217.5%) | $5.79 M(+66.8%) |
| Dec 2021 | $3.47 M(+79.8%) | $880.00 K(-49.3%) | $3.47 M(+30.7%) |
| Sep 2021 | - | $1.74 M(+358.0%) | $2.65 M(+188.9%) |
| Jun 2021 | - | $379.00 K(-20.4%) | $919.00 K(+70.2%) |
| Mar 2021 | - | $476.00 K(+643.8%) | $540.00 K(+743.8%) |
| Dec 2020 | $1.93 M | $64.00 K | $64.00 K |
FAQ
- What is Relay Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Relay Therapeutics?
- What is Relay Therapeutics annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Relay Therapeutics?
- What is the all time high TTM CAPEX for Relay Therapeutics?
What is Relay Therapeutics annual capital expenditures?
The current annual CAPEX of RLAY is $4.13 M
What is the all time high annual CAPEX for Relay Therapeutics?
Relay Therapeutics all-time high annual capital expenditures is $9.06 M
What is Relay Therapeutics annual CAPEX year-on-year change?
Over the past year, RLAY annual capital expenditures has changed by -$4.94 M (-54.47%)
What is the all time high quarterly CAPEX for Relay Therapeutics?
Relay Therapeutics all-time high quarterly capital expenditures is $2.79 M
What is the all time high TTM CAPEX for Relay Therapeutics?
Relay Therapeutics all-time high TTM capital expenditures is $9.06 M